Background: Inflammation influences cancer development and progression. An elevated
platelet to lymphocyte ratio (PLR), a marker of inflammation, has been linked to poor …

Background Pre-treatment PLR (platelet-lymphocyte ratio) was reported to be associated
with the prognosis in gastric cancer (GC), but the results remain inconclusive. This meta …

Objectives In this study, they investigated whether mean thrombocyte volume (MPV) and
MPV/platelet count ratio have a prognostic significance in advanced NSCLC or not. Methods …

The platelet-to-lymphocyte ratio (PLR) is a useful prognostic factor in several cancers.
However, the prognostic role of PLR in esophageal cancer remains controversial. The aim of …

Background: Inflammation plays an important role in tumor progression. Predicting survival
is remarkably difficult in patients with gastric cancer receiving neoadjuvant chemotherapy …

Activated platelets promote cancer progression and metastasis. Nevertheless, the
prognostic value of platelet indices in melanoma had been rarely reported. The aim of this …

Thyroid cancer is the most prevalent endocrine cancer and is evident in nearly 5% of thyroid
nodules. The correlation between mean platelet volume (MPV) and many other cancer types …

Background Solid tumors are a common cause of secondary (reactive) thrombocytosis, a
paraneoplastic syndrome that is also a prognostic factor for various cancers. However, cutoff …

The interaction between cancer cells and platelets has been known for a long time. Although
platelet indices have been also investigated in several clinical settings, it has not been …

Background: Increasing amounts of evidence suggest patient-related systemic inflammatory
response (SIR) as a powerful prognostic factor in cancer and applicability of SIR as a …